- Home
- CATX vs TKNO Comparison
CATX vs TKNO Comparison
Compare CATX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATX | TKNO |
|---|---|---|
| Founded | 1983 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.1M | 214.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CATX | TKNO |
|---|---|---|
| Price | $4.84 | $2.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.78 | N/A |
| AVG Volume (30 Days) | ★ 7.1M | 378.0K |
| Earning Date | 03-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,075,000.00 | ★ $39,801,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $1.60 | $1.91 |
| 52 Week High | $6.16 | $9.10 |
Technical Indicators
Market Signals| Indicator | CATX | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 66.96 | 17.00 |
| Support Level | $4.37 | $1.96 |
| Resistance Level | $5.00 | $2.54 |
| Average True Range (ATR) | 0.79 | 0.27 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 63.47 | 12.69 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.